Introduction
Hypertension is a sustained elevation of systemic arterial pressure 1 . Essential hypertension accounts for 90-95% of all cases of hypertension. Essential hypertension means hypertension which is of unknown origin 2 . Now a days, hypertension has become a significant public health challenge throughout the world because of its high prevalence 3 .
In Bangladesh the prevalence rate of hypertension is also very high and more than 20% of the adults have hypertension 4 . Hypertension has been linked to multiple other diseases including cardiac, cerebrovascular, renal and eye diseases 5 . Several studies showed that hypertension and lung function are also associated 
Methods
This prospective observational study was carried out in the Department of Physiology of Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka, from July 2012 to June 2013. Hundred newly diagnosed hypertensive patients aged between 30-55 years were selected as study group. Age, sex and BMI matched 50 apparently healthy normotensive subjects were also studied as control (group A). Based on treatment, these study subjects were divided into two groups; B1 and B2. B1 included 50 patients who received losartan 50mg daily and B2 included 50 patients who received atenolol 50mg daily. Again group B1 was divided into -B1 a (newly diagnosed hypertensive patients before treatment), B1 b (after 3 months of medication with losartan) and B1 c (after 6 months medication with losartan). Similarly subjects of group B2 were divided into B2 a (newly diagnosed hypertensive patients before treatment) , B2 b (after 3 months of medication with atenolol) and B2 c (after 6 months medication with atenolol). These patients were selected from the Out Patient Department of Cardiology unit, BSMMU.
Subjects with history of acute or chronic lung and chest wall disease e.g. pneumonia, tuberculosis, asthma, COPD, malignancy etc, and with history of coronary heart disease, diabetes mellitus and also the alcohol/tobacco users and smokers were excluded from the study. After random selection of the subjects a detail personal, medical, family, socioeconomic, occupational and drug history were recorded in a preformed questionnaire and thorough physical examinations were done and documented. For the assessment of lung function, FVC, FEV 1 and PEFR were measured with a computer based Spirometer.
Then all the patients were requested to attend Department of Physiology, BSMMU again after 3 months and after 6 months of antihypertensive medication to have the assessment of the above mentioned study variables. For statistical analysis independent sample 't' test and paired sample 't' test were performed by using SPSS (statistical package for social sciences) for windows version 16.0 as applicable. P value <0.05 was accepted as level of significance. The exact mechanisms involved for the decrement of lung functions in hypertension and improvement after treatment with losartan but not with atenolol in hypertensive groups of present study cannot be elucidated from this type of study. However, it is assumed that all the above mentioned mechanisms may influence the degree of deterioration of these variables in hypertensive patients and improvement after treatment with losartan but not with atenolol.
Conclusion
The ventilatory variables decrease in newly diagnosed patients with essential hypertension and lung function status improves after treatment with losartan but decreases after treatment with atenolol. Apart from the suggested mechanism by several investigators these decrement may be associated with silent pulmonary disorders without presenting any pulmonary symptoms.
